nodes	percent_of_prediction	percent_of_DWPC	metapath
Balsalazide—PTGS2—Etoposide—uterine cancer	0.285	0.542	CbGbCtD
Balsalazide—PTGS1—Etoposide—uterine cancer	0.24	0.458	CbGbCtD
Balsalazide—PPARG—artery—uterine cancer	0.0259	0.0873	CbGeAlD
Balsalazide—PTGS1—oviduct—uterine cancer	0.0209	0.0705	CbGeAlD
Balsalazide—PPARG—Teniposide—Etoposide—uterine cancer	0.0178	1	CbGdCrCtD
Balsalazide—PTGS1—artery—uterine cancer	0.0139	0.0467	CbGeAlD
Balsalazide—PTGS2—artery—uterine cancer	0.0133	0.0446	CbGeAlD
Balsalazide—ALOX5—smooth muscle tissue—uterine cancer	0.0126	0.0425	CbGeAlD
Balsalazide—ALOX5—decidua—uterine cancer	0.0124	0.0417	CbGeAlD
Balsalazide—PPARG—epithelium—uterine cancer	0.00984	0.0331	CbGeAlD
Balsalazide—ALOX5—female reproductive system—uterine cancer	0.00973	0.0328	CbGeAlD
Balsalazide—PPARG—smooth muscle tissue—uterine cancer	0.00948	0.0319	CbGeAlD
Balsalazide—PPARG—decidua—uterine cancer	0.00929	0.0313	CbGeAlD
Balsalazide—PPARG—renal system—uterine cancer	0.00913	0.0307	CbGeAlD
Balsalazide—ALOX5—female gonad—uterine cancer	0.00886	0.0298	CbGeAlD
Balsalazide—PPARG—mammalian vulva—uterine cancer	0.00853	0.0287	CbGeAlD
Balsalazide—PPARG—uterus—uterine cancer	0.00813	0.0274	CbGeAlD
Balsalazide—PPARG—female reproductive system—uterine cancer	0.00731	0.0246	CbGeAlD
Balsalazide—PPARG—female gonad—uterine cancer	0.00665	0.0224	CbGeAlD
Balsalazide—PPARG—vagina—uterine cancer	0.00661	0.0222	CbGeAlD
Balsalazide—PTGS2—myometrium—uterine cancer	0.00641	0.0216	CbGeAlD
Balsalazide—ALOX5—lymph node—uterine cancer	0.00569	0.0192	CbGeAlD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—CHD4—uterine cancer	0.00564	0.0353	CbGpPWpGaD
Balsalazide—PTGS1—epithelium—uterine cancer	0.00526	0.0177	CbGeAlD
Balsalazide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—uterine cancer	0.00523	0.0327	CbGpPWpGaD
Balsalazide—PTGS1—uterine cervix—uterine cancer	0.00521	0.0176	CbGeAlD
Balsalazide—ALOX5—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00511	0.0319	CbGpPWpGaD
Balsalazide—PTGS1—smooth muscle tissue—uterine cancer	0.00507	0.0171	CbGeAlD
Balsalazide—PTGS2—epithelium—uterine cancer	0.00503	0.0169	CbGeAlD
Balsalazide—PTGS2—uterine cervix—uterine cancer	0.00498	0.0168	CbGeAlD
Balsalazide—PTGS1—renal system—uterine cancer	0.00488	0.0164	CbGeAlD
Balsalazide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—uterine cancer	0.00487	0.0304	CbGpPWpGaD
Balsalazide—PTGS2—smooth muscle tissue—uterine cancer	0.00484	0.0163	CbGeAlD
Balsalazide—PTGS1—endometrium—uterine cancer	0.00472	0.0159	CbGeAlD
Balsalazide—PTGS2—renal system—uterine cancer	0.00466	0.0157	CbGeAlD
Balsalazide—PTGS1—mammalian vulva—uterine cancer	0.00456	0.0154	CbGeAlD
Balsalazide—PTGS2—endometrium—uterine cancer	0.00451	0.0152	CbGeAlD
Balsalazide—PTGS1—uterus—uterine cancer	0.00435	0.0146	CbGeAlD
Balsalazide—PPARG—lymph node—uterine cancer	0.00428	0.0144	CbGeAlD
Balsalazide—PTGS2—uterus—uterine cancer	0.00415	0.014	CbGeAlD
Balsalazide—PTGS1—female reproductive system—uterine cancer	0.00391	0.0131	CbGeAlD
Balsalazide—PPARG—Nuclear Receptors—PGR—uterine cancer	0.00384	0.024	CbGpPWpGaD
Balsalazide—PTGS2—female reproductive system—uterine cancer	0.00373	0.0126	CbGeAlD
Balsalazide—ALOX5—Selenium Micronutrient Network—GPX3—uterine cancer	0.0037	0.0232	CbGpPWpGaD
Balsalazide—PTGS1—female gonad—uterine cancer	0.00356	0.012	CbGeAlD
Balsalazide—PTGS1—vagina—uterine cancer	0.00353	0.0119	CbGeAlD
Balsalazide—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.00353	0.0221	CbGpPWpGaD
Balsalazide—PTGS2—female gonad—uterine cancer	0.0034	0.0114	CbGeAlD
Balsalazide—PTGS2—vagina—uterine cancer	0.00338	0.0114	CbGeAlD
Balsalazide—PPARG—Nuclear Receptors—ESR2—uterine cancer	0.00338	0.0211	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00303	0.019	CbGpPWpGaD
Balsalazide—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—uterine cancer	0.0028	0.0175	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.00267	0.0167	CbGpPWpGaD
Balsalazide—PTGS1—lymph node—uterine cancer	0.00229	0.00769	CbGeAlD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.00225	0.014	CbGpPWpGaD
Balsalazide—PTGS1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00221	0.0138	CbGpPWpGaD
Balsalazide—PTGS2—lymph node—uterine cancer	0.00218	0.00735	CbGeAlD
Balsalazide—PPARG—Nuclear Receptors—ESR1—uterine cancer	0.00205	0.0128	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—MTHFR—uterine cancer	0.0019	0.0119	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—STAR—uterine cancer	0.00184	0.0115	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00179	0.0112	CbGpPWpGaD
Balsalazide—PTGS2—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00176	0.011	CbGpPWpGaD
Balsalazide—PTGS1—Overview of nanoparticle effects—CXCL8—uterine cancer	0.00174	0.0109	CbGpPWpGaD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00164	0.0103	CbGpPWpGaD
Balsalazide—PPARG—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00162	0.0101	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—GPX3—uterine cancer	0.00161	0.01	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00155	0.00971	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—HNF1B—uterine cancer	0.0015	0.00937	CbGpPWpGaD
Balsalazide—ALOX5—Selenium Micronutrient Network—CCL2—uterine cancer	0.00149	0.00931	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—HMGA1—uterine cancer	0.00143	0.00897	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—PLXNA3—uterine cancer	0.00139	0.00869	CbGpPWpGaD
Balsalazide—PTGS2—Overview of nanoparticle effects—CXCL8—uterine cancer	0.00138	0.00863	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—MET—uterine cancer	0.00132	0.00827	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00129	0.00808	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00129	0.00808	CbGpPWpGaD
Balsalazide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	0.00129	0.00805	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—GPX3—uterine cancer	0.00128	0.00797	CbGpPWpGaD
Balsalazide—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine cancer	0.00122	0.00761	CbGpPWpGaD
Balsalazide—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00121	0.00756	CbGpPWpGaD
Balsalazide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	0.00114	0.00716	CbGpPWpGaD
Balsalazide—PTGS2—S1P1 pathway—VEGFA—uterine cancer	0.00112	0.00701	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00111	0.00691	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—SOCS3—uterine cancer	0.00107	0.00671	CbGpPWpGaD
Balsalazide—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—uterine cancer	0.00102	0.0064	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—CDKN2A—uterine cancer	0.00101	0.00632	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000978	0.00611	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—EZH2—uterine cancer	0.000961	0.00601	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000948	0.00593	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—SMAD3—uterine cancer	0.000938	0.00587	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—CDKN1B—uterine cancer	0.000895	0.0056	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—CYP11A1—uterine cancer	0.000872	0.00546	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000868	0.00543	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000825	0.00516	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000799	0.005	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000799	0.005	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—NDUFB11—uterine cancer	0.000795	0.00497	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—SRD5A2—uterine cancer	0.000795	0.00497	CbGpPWpGaD
Balsalazide—PPARG—Regulation of retinoblastoma protein—EP300—uterine cancer	0.000786	0.00492	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000774	0.00484	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000773	0.00483	CbGpPWpGaD
Balsalazide—PPARG—Signaling events mediated by HDAC Class I—EP300—uterine cancer	0.00075	0.00469	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.00073	0.00456	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—HNF1B—uterine cancer	0.00073	0.00456	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—PHF1—uterine cancer	0.00071	0.00444	CbGpPWpGaD
Balsalazide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—uterine cancer	0.000695	0.00435	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000664	0.00416	CbGpPWpGaD
Balsalazide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.000661	0.00413	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000655	0.00409	CbGpPWpGaD
Balsalazide—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.000645	0.00404	CbGpPWpGaD
Balsalazide—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000642	0.00401	CbGpPWpGaD
Balsalazide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	0.000637	0.00398	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000615	0.00385	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—CHD4—uterine cancer	0.000604	0.00378	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000587	0.00367	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000583	0.00365	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—AKR1B1—uterine cancer	0.000575	0.0036	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—STAR—uterine cancer	0.000575	0.0036	CbGpPWpGaD
Balsalazide—PPARG—Wnt Signaling Pathway Netpath—AKT1—uterine cancer	0.000575	0.0036	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000568	0.00356	CbGpPWpGaD
Balsalazide—PPARG—SREBP signalling—PIK3CA—uterine cancer	0.000561	0.00351	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00056	0.0035	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00056	0.0035	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000557	0.00348	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000553	0.00346	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000546	0.00341	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—PGR—uterine cancer	0.000524	0.00327	CbGpPWpGaD
Balsalazide—PPARG—PPARA activates gene expression—EP300—uterine cancer	0.000522	0.00327	CbGpPWpGaD
Balsalazide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	0.00052	0.00325	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000516	0.00323	CbGpPWpGaD
Balsalazide—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	0.000512	0.0032	CbGpPWpGaD
Balsalazide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000511	0.0032	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—SUZ12—uterine cancer	0.000506	0.00317	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—NDUFB11—uterine cancer	0.000492	0.00308	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—SRD5A2—uterine cancer	0.000492	0.00308	CbGpPWpGaD
Balsalazide—PPARG—Adipogenesis—CTNNB1—uterine cancer	0.000492	0.00308	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000478	0.00299	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.00047	0.00294	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000469	0.00293	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000463	0.0029	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—ESR2—uterine cancer	0.000461	0.00288	CbGpPWpGaD
Balsalazide—PPARG—SREBP signalling—AKT1—uterine cancer	0.000458	0.00287	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000452	0.00282	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—POLD1—uterine cancer	0.000451	0.00282	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000444	0.00278	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000444	0.00278	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—AKR1C1—uterine cancer	0.000422	0.00264	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00042	0.00263	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000411	0.00257	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	0.00041	0.00257	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	0.000405	0.00253	CbGpPWpGaD
Balsalazide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000399	0.0025	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—RRM2—uterine cancer	0.000376	0.00235	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000375	0.00235	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—DCN—uterine cancer	0.000365	0.00228	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	0.00036	0.00225	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—AKR1B1—uterine cancer	0.000356	0.00223	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—STAR—uterine cancer	0.000356	0.00223	CbGpPWpGaD
Balsalazide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000352	0.0022	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000352	0.0022	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—NDUFB11—uterine cancer	0.000345	0.00216	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—SRD5A2—uterine cancer	0.000345	0.00216	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CYP11A1—uterine cancer	0.000344	0.00215	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000343	0.00214	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—PTEN—uterine cancer	0.000338	0.00212	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	0.000337	0.00211	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000335	0.0021	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000326	0.00204	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—AKR1C3—uterine cancer	0.000325	0.00203	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—EP300—uterine cancer	0.000322	0.00202	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—SMAD3—uterine cancer	0.000322	0.00202	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	0.00032	0.002	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000316	0.00198	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000313	0.00196	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	0.000313	0.00196	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	0.00029	0.00182	CbGpPWpGaD
Balsalazide—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	0.00028	0.00175	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—POLD1—uterine cancer	0.000279	0.00175	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—NDUFB11—uterine cancer	0.000274	0.00171	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—SRD5A2—uterine cancer	0.000274	0.00171	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000266	0.00166	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—MET—uterine cancer	0.000264	0.00165	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—AKR1C1—uterine cancer	0.000261	0.00163	CbGpPWpGaD
Balsalazide—PTGS2—Disease—AKR1B10—uterine cancer	0.000254	0.00159	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—CYP19A1—uterine cancer	0.000253	0.00158	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—STK11—uterine cancer	0.000253	0.00158	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—PGR—uterine cancer	0.000252	0.00158	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000251	0.00157	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—STAR—uterine cancer	0.000249	0.00156	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—AKR1B1—uterine cancer	0.000249	0.00156	CbGpPWpGaD
Balsalazide—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	0.000247	0.00154	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000246	0.00154	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—EZH2—uterine cancer	0.000239	0.0015	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000238	0.00149	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—RRM2—uterine cancer	0.000233	0.00146	CbGpPWpGaD
Balsalazide—PPARG—Circadian rythm related genes—TP53—uterine cancer	0.000231	0.00144	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.00023	0.00144	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000227	0.00142	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—DCN—uterine cancer	0.000226	0.00141	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ESR2—uterine cancer	0.000222	0.00139	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CYP11A1—uterine cancer	0.000213	0.00133	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000213	0.00133	CbGpPWpGaD
Balsalazide—PTGS2—Disease—RNF43—uterine cancer	0.000211	0.00132	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—AKR1C3—uterine cancer	0.000201	0.00126	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000201	0.00126	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—STAR—uterine cancer	0.000198	0.00124	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—AKR1B1—uterine cancer	0.000198	0.00124	CbGpPWpGaD
Balsalazide—PTGS2—Spinal Cord Injury—TP53—uterine cancer	0.000197	0.00123	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000196	0.00123	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—POLD1—uterine cancer	0.000196	0.00122	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000196	0.00122	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—ERBB2—uterine cancer	0.000193	0.00121	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—MTHFR—uterine cancer	0.00019	0.00119	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000187	0.00117	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—AKR1C1—uterine cancer	0.000183	0.00114	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—CDKN2B—uterine cancer	0.000181	0.00113	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000177	0.00111	CbGpPWpGaD
Balsalazide—PTGS2—Disease—AKR1C1—uterine cancer	0.000173	0.00109	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—CTNNB1—uterine cancer	0.000169	0.00106	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000168	0.00105	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—SMAD3—uterine cancer	0.000165	0.00103	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—RRM2—uterine cancer	0.000163	0.00102	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—DCN—uterine cancer	0.000158	0.000991	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—EP300—uterine cancer	0.000157	0.000982	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—STK11—uterine cancer	0.000157	0.00098	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—CYP19A1—uterine cancer	0.000157	0.00098	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—POLD1—uterine cancer	0.000155	0.000972	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.00015	0.000941	CbGpPWpGaD
Balsalazide—PTGS2—Disease—DCN—uterine cancer	0.00015	0.000939	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CYP11A1—uterine cancer	0.000149	0.000933	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—VEGFA—uterine cancer	0.000149	0.00093	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000147	0.00092	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—NRAS—uterine cancer	0.000147	0.000919	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—AKR1C1—uterine cancer	0.000145	0.000909	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—AKR1C3—uterine cancer	0.000141	0.000881	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.00014	0.000877	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000138	0.000864	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—ESR1—uterine cancer	0.000135	0.000842	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000134	0.000836	CbGpPWpGaD
Balsalazide—PTGS2—Disease—AKR1C3—uterine cancer	0.000134	0.000835	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HMGA1—uterine cancer	0.00013	0.000814	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—RRM2—uterine cancer	0.00013	0.00081	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—KRAS—uterine cancer	0.000126	0.000791	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—DCN—uterine cancer	0.000126	0.000786	CbGpPWpGaD
Balsalazide—PTGS2—Disease—FBXW7—uterine cancer	0.000119	0.000745	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CYP11A1—uterine cancer	0.000118	0.000741	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—MTHFR—uterine cancer	0.000118	0.000736	CbGpPWpGaD
Balsalazide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000113	0.000706	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—AKR1C3—uterine cancer	0.000112	0.0007	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—CYP19A1—uterine cancer	0.00011	0.000687	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—STK11—uterine cancer	0.00011	0.000687	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—HRAS—uterine cancer	0.000107	0.000672	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PTEN—uterine cancer	0.000106	0.000662	CbGpPWpGaD
Balsalazide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000104	0.000649	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000103	0.000644	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—EP300—uterine cancer	0.000101	0.000631	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.83e-05	0.000615	CbGpPWpGaD
Balsalazide—PPARG—Developmental Biology—AKT1—uterine cancer	9.49e-05	0.000594	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CDKN2B—uterine cancer	9.33e-05	0.000583	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—STK11—uterine cancer	8.71e-05	0.000545	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—CYP19A1—uterine cancer	8.71e-05	0.000545	CbGpPWpGaD
Balsalazide—PTGS2—Disease—SMAD3—uterine cancer	8.52e-05	0.000533	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—MTHFR—uterine cancer	8.25e-05	0.000516	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.18e-05	0.000512	CbGpPWpGaD
Balsalazide—PTGS2—Disease—FGFR2—uterine cancer	8.12e-05	0.000508	CbGpPWpGaD
Balsalazide—PTGS2—Disease—MTHFR—uterine cancer	7.82e-05	0.000489	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.8e-05	0.000488	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—PIK3CA—uterine cancer	7.47e-05	0.000467	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.27e-05	0.000455	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PTEN—uterine cancer	6.55e-05	0.00041	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—MTHFR—uterine cancer	6.55e-05	0.00041	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—EP300—uterine cancer	6.25e-05	0.000391	CbGpPWpGaD
Balsalazide—ALOX5—Metabolism—AKT1—uterine cancer	6.1e-05	0.000381	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.77e-05	0.000361	CbGpPWpGaD
Balsalazide—PTGS2—Disease—ERBB2—uterine cancer	5.1e-05	0.000319	CbGpPWpGaD
Balsalazide—PPARG—Gene Expression—AKT1—uterine cancer	4.86e-05	0.000304	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CDKN1B—uterine cancer	4.72e-05	0.000295	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—PIK3CA—uterine cancer	4.62e-05	0.000289	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PTEN—uterine cancer	4.59e-05	0.000287	CbGpPWpGaD
Balsalazide—PTGS2—Disease—CTNNB1—uterine cancer	4.46e-05	0.000279	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—EP300—uterine cancer	4.38e-05	0.000274	CbGpPWpGaD
Balsalazide—PTGS2—Disease—PTEN—uterine cancer	4.35e-05	0.000272	CbGpPWpGaD
Balsalazide—PTGS2—Disease—EP300—uterine cancer	4.15e-05	0.000259	CbGpPWpGaD
Balsalazide—PTGS2—Disease—NRAS—uterine cancer	3.88e-05	0.000243	CbGpPWpGaD
Balsalazide—PPARG—Metabolism—AKT1—uterine cancer	3.78e-05	0.000236	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—PTEN—uterine cancer	3.64e-05	0.000228	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—EP300—uterine cancer	3.47e-05	0.000217	CbGpPWpGaD
Balsalazide—PTGS2—Disease—KRAS—uterine cancer	3.34e-05	0.000209	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—PIK3CA—uterine cancer	3.24e-05	0.000202	CbGpPWpGaD
Balsalazide—PTGS2—Disease—PIK3CA—uterine cancer	3.07e-05	0.000192	CbGpPWpGaD
Balsalazide—PTGS2—Disease—HRAS—uterine cancer	2.84e-05	0.000178	CbGpPWpGaD
Balsalazide—PTGS1—Metabolism—AKT1—uterine cancer	2.64e-05	0.000165	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—PIK3CA—uterine cancer	2.57e-05	0.000161	CbGpPWpGaD
Balsalazide—PTGS2—Disease—AKT1—uterine cancer	2.51e-05	0.000157	CbGpPWpGaD
Balsalazide—PTGS2—Metabolism—AKT1—uterine cancer	2.1e-05	0.000131	CbGpPWpGaD
